Medicure (MPH)

Last close As at 18/11/2026

CAD3.51

▲ −0.24 (−6.40%)

Market capitalisation

CAD40m

Winnipeg-based Medicure is focused on advancing and marketing pharmaceuticals and healthcare products for the US market. Aggrastat and Zypitamag are commercialised in the US cardiovascular segments, and Medicure also operates a US pharmacy subsidiary, Marley Drug. It is also advancing MC-1 in a Phase III study for a rare paediatric seizure indication.

Latest Insights

Healthcare | Quickview

Medicure — A growing US-focused specialty pharma

Share Price Chart

Market Data

Share Price CAD3.51
Market Cap CAD40m
52-Week High CAD4.95
52-Week Low CAD0.85
% Change 1M (12.8)
% Change 6M 240.9
% Change 12M 190.7
Ave. Daily Volume 1yr 4,974

Sector

Healthcare

Equity Analyst

Key Management

  • Albert D. Friesen

    CEO

  • James Kinley

    CFO

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.